Original paper
Real-world experience of ocrelizumab in multiple sclerosis in an Arab population
Abstract
Objective Pivotal clinical trials revealed good clinical efficiency of ocrelizumab while having a good safety profile in the management of multiple sclerosis (MS). However, real-world data of ocrelizumab in daily clinical practice remain scarce. The aim of this study was to evaluate the preliminary safety profile and effectiveness of ocrelizumab treatment for MS in an Arab population in a real-world clinical setting.Methods In this retrospective...
Paper Details
Title
Real-world experience of ocrelizumab in multiple sclerosis in an Arab population
Published Date
Oct 19, 2021
Journal
Volume
10
Issue
1
Pages
106 - 113
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History